These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23262199)

  • 1. Biocompatibility of engineered nanoparticles for drug delivery.
    Naahidi S; Jafari M; Edalat F; Raymond K; Khademhosseini A; Chen P
    J Control Release; 2013 Mar; 166(2):182-94. PubMed ID: 23262199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered nanoparticles as precise drug delivery systems.
    Yih TC; Al-Fandi M
    J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and advances in nanoparticle-based oral insulin delivery.
    Ramesan RM; Sharma CP
    Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of new chitosan/carrageenan nanoparticles for drug delivery applications.
    Grenha A; Gomes ME; Rodrigues M; Santo VE; Mano JF; Neves NM; Reis RL
    J Biomed Mater Res A; 2010 Mar; 92(4):1265-72. PubMed ID: 19322874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-biocompatibility relationship of dendritic polyglycerol derivatives.
    Khandare J; Mohr A; Calderón M; Welker P; Licha K; Haag R
    Biomaterials; 2010 May; 31(15):4268-77. PubMed ID: 20206990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in the investigation of biological effect and surface modification of dendrimers as drug (gene) delivery systems].
    He ZH; Kong H; Xu HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):590-5. PubMed ID: 16995320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: nanoparticles in drug delivery for the treatment of cancer.
    Arayne MS; Sultana N
    Pak J Pharm Sci; 2006 Jul; 19(3):258-68. PubMed ID: 16935836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the nature of biomaterials.
    Williams DF
    Biomaterials; 2009 Oct; 30(30):5897-909. PubMed ID: 19651435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
    Rosenholm JM; Sahlgren C; Lindén M
    Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence nanoparticles "quantum dots" as drug delivery system and their toxicity: a review.
    Ghaderi S; Ramesh B; Seifalian AM
    J Drug Target; 2011 Aug; 19(7):475-86. PubMed ID: 20964619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered nonviral nanocarriers for intracellular gene delivery applications.
    Ojea-Jiménez I; Tort O; Lorenzo J; Puntes VF
    Biomed Mater; 2012 Oct; 7(5):054106. PubMed ID: 22972254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
    Tomalia DA; Reyna LA; Svenson S
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):61-7. PubMed ID: 17233602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-functionalized nanoparticles: from stealth viruses to biocompatible quantum dots.
    Jia H; Titmuss S
    Nanomedicine (Lond); 2009 Dec; 4(8):951-66. PubMed ID: 19958231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(methyl methacrylate) particulate carriers in drug delivery.
    Bettencourt A; Almeida AJ
    J Microencapsul; 2012; 29(4):353-67. PubMed ID: 22251239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles.
    Malyala P; O'Hagan DT; Singh M
    Adv Drug Deliv Rev; 2009 Mar; 61(3):218-25. PubMed ID: 19168103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new generation of polymer nanoparticles for drug delivery.
    Chauvierre C; Vauthier C; Labarre D; Couvreur P; Marden MC; Leclerc L
    Cell Mol Biol (Noisy-le-grand); 2004 May; 50(3):233-9. PubMed ID: 15209344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents.
    Namazi H; Adeli M
    Biomaterials; 2005 Apr; 26(10):1175-83. PubMed ID: 15451637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution.
    Imran ul-haq M; Lai BF; Chapanian R; Kizhakkedathu JN
    Biomaterials; 2012 Dec; 33(35):9135-47. PubMed ID: 23020861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.